2010
DOI: 10.1086/653011
|View full text |Cite
|
Sign up to set email alerts
|

Emergence of Cytomegalovirus Disease in Patients Receiving Temozolomide: Report of Two Cases and Literature Review

Abstract: Temozolomide chemotherapy has become part of the therapy used to treat glioblastoma multiforme and refractory anaplastic astrocytoma. Temozolomide frequently produces profound lymphopenia. We report 2 cases of cytomegalovirus disease that occurred in patients receiving temozolomide therapy and review 4 additional cases reported in the literature. Narrow monitoring with cytomegalovirus antigenemia assay should be considered for recommendation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(30 citation statements)
references
References 17 publications
0
30
0
Order By: Relevance
“…The incidence and risk factors of temozolomide-induced CMV reactivation, as well as its optimal management, remain unclear. Steroids also causes immunosuppression and the majority of reported cases of opportunistic CMV infection occurred when patients were treated concurrently with temozolomide and steroids [4,[6][7][8][9], including our case. Therefore, treatment with temozolomide in combination with steroids is supposed to be the cause of immunosuppression and subsequent CMV reactivation.…”
Section: Discussionmentioning
confidence: 74%
See 3 more Smart Citations
“…The incidence and risk factors of temozolomide-induced CMV reactivation, as well as its optimal management, remain unclear. Steroids also causes immunosuppression and the majority of reported cases of opportunistic CMV infection occurred when patients were treated concurrently with temozolomide and steroids [4,[6][7][8][9], including our case. Therefore, treatment with temozolomide in combination with steroids is supposed to be the cause of immunosuppression and subsequent CMV reactivation.…”
Section: Discussionmentioning
confidence: 74%
“…T-cell dysfunction, treatment with temozolomide is possibly associated with a decline of the immune system and an increased susceptibility to opportunistic infections such as PCP [3,4]. This characteristic immunosuppression also induces CMV reactivation as a rare complication [4,[6][7][8][9]. The incidence and risk factors of temozolomide-induced CMV reactivation, as well as its optimal management, remain unclear.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In addition, there has been a report of two cases of CMV infection associated with TMZ [9]. In this report, 4 additional cases of CMV infection were culled from the literature and 5 of the 6 cases involved TMZ administration with corticosteroids with evidence of CMV pneumonitis in 3 patients.…”
Section: Discussionmentioning
confidence: 95%